Frontlight ResearchEarly access
CompletedNo phase
BEnefit of Arterial Preparation by LONGitudinal Scoring
Key facts
- Who runs it
- VentureMed Group Inc.
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 150 people enrolled
- Started
- 24 Oct 2018
- Ended
- 4 Mar 2024
- Type of study
- Interventional
- Treatments tested
- FLEX Scoring Catheter
- Record updated
- 12 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (19)Hide the full registry criteria
Who can take part
- Patients ≥ 18-year-old, with symptomatic lower extremity occlusive arterial disease
- Rutherford class of symptom 2 to 5
- Atheromatous ≥ 70 % stenosis or occlusion of SFA and/or PA
- Absence of > 50% residual stenosis of the run-in vessels at the end of procedure
- Presence of at least one patent (no ≥ 50 % stenosis) run-off tibial or fibular vessel to the foot at the end of procedure
- De novo or restenotic lesions, including in-stent restenosis
- Willingness to participate in the study and signature of informed consent
Who cannot take part
- Previous use of a PCB in the lesion during last 15 months
- Previous or planned surgery of the target lesion
- Contra-indication to dual antiplatelet therapy for one month, and/or to single antiplatelet therapy for 1 year
- Recent artery thrombosis, at risk of distal embolization during percutaneous procedure
- High risk of bleeding
- Allergy to aspirin, clopidogrel or heparin
- Renal failure with glomerular filtration rate (GFR) 30 ml/min or below, estimated by the Cockroft-Gault equation
- Women who are pregnant, lactating, or planning to become pregnant during the duration of the study
- Extremely calcified lesions, defined by calcification involving ³ 270° of the artery circumference over ³ 15 cm
- Sub-intimal recanalization
- Tortuous contra-lateral femoral access with difficult cross-over
- Life expectancy less than one year
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of the artery preparation concept is to perform regular longitudinal micro-incisions on the inner side of the artery ("scoring") and therefore promote a regular expansion of atheroma by balloon inflation.
The group in the trial
- FLEX Scoring Catheter plus DEBTreatment being tested
The target lesion is prepared by the FLEX Scoring Catheter® with a 30° rotation between each passage. Angioplasty is performed during 3 minutes with paclitaxel-coated balloon(s) (PCB), all along the target lesion.
Treatment: FLEX Scoring Catheter
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- BEnefit of Arterial Preparation by LONGitudinal Scoring Before Paclitaxel Eluting Balloon Angioplasty of the Superficial Femoral and Popliteal Artery
- Record updated
- 12 December 2024